14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ADMS
Delisted

Adamas Pharmaceuticals Stock Price (Quote)

$8.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $8.22 $8.22 Friday, 27th May 2022 ADMS stock ended at $8.22. During the day the stock fluctuated 0% from a day low at $8.22 to a day high of $8.22.
90 days $8.22 $8.22
52 weeks $4.02 $8.25

Historical Adamas Pharmaceuticals prices

Date Open High Low Close Volume
Aug 19, 2019 $6.50 $6.66 $6.15 $6.20 203 176
Aug 16, 2019 $6.34 $6.72 $6.25 $6.42 302 908
Aug 15, 2019 $6.05 $6.32 $5.99 $6.28 452 700
Aug 14, 2019 $6.13 $6.25 $6.02 $6.06 822 681
Aug 13, 2019 $6.43 $6.59 $6.12 $6.22 226 134
Aug 12, 2019 $6.06 $6.52 $6.06 $6.40 238 236
Aug 09, 2019 $6.10 $6.12 $4.87 $6.05 948 802
Aug 08, 2019 $6.01 $6.47 $6.01 $6.12 334 199
Aug 07, 2019 $6.01 $6.16 $5.94 $6.01 337 105
Aug 06, 2019 $6.04 $6.14 $5.85 $6.05 383 194
Aug 05, 2019 $6.00 $6.05 $5.90 $6.00 485 019
Aug 02, 2019 $6.01 $6.14 $5.90 $6.10 267 197
Aug 01, 2019 $6.27 $6.49 $5.99 $6.01 349 709
Jul 31, 2019 $6.21 $6.58 $6.10 $6.26 393 512
Jul 30, 2019 $5.97 $6.26 $5.93 $6.19 165 017
Jul 29, 2019 $6.01 $6.10 $5.89 $6.00 227 602
Jul 26, 2019 $6.04 $6.07 $6.00 $6.01 202 764
Jul 25, 2019 $6.02 $6.06 $5.97 $6.03 297 853
Jul 24, 2019 $6.00 $6.12 $5.93 $6.05 276 565
Jul 23, 2019 $6.02 $6.13 $5.94 $6.00 159 955
Jul 22, 2019 $6.00 $6.10 $5.90 $6.00 256 903
Jul 19, 2019 $6.02 $6.10 $5.94 $6.00 224 625
Jul 18, 2019 $5.99 $6.04 $5.83 $6.03 184 444
Jul 17, 2019 $6.01 $6.03 $5.90 $5.99 887 036
Jul 16, 2019 $5.94 $6.08 $5.89 $6.01 165 725
Click to get the best stock tips daily for free!

About Adamas Pharmaceuticals

Adamas Pharmaceuticals Adamas Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company’s lead product candidate is the ADS-5102 that is in Phase 3 clinical development for the treatment of levodopa-induced dyskinesia, a movement disorder associated with Parkinson’s disease; and in a Phase 2 clinical study for the treatment of symptoms assoc... ADMS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT